These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 31877491)
1. Neuronal oscillations of the pedunculopontine nucleus in progressive supranuclear palsy: Influence of levodopa and movement. Galazky I; Zaehle T; Sweeney-Reed CM; Neumann J; Heinze HJ; Voges J; Kupsch A; Hinrichs H Clin Neurophysiol; 2020 Feb; 131(2):414-419. PubMed ID: 31877491 [TBL] [Abstract][Full Text] [Related]
2. Neuronal spiking in the pedunculopontine nucleus in progressive supranuclear palsy and in idiopathic Parkinson's disease. Galazky I; Kaufmann J; Voges J; Hinrichs H; Heinze HJ; Sweeney-Reed CM J Neurol; 2019 Sep; 266(9):2244-2251. PubMed ID: 31155683 [TBL] [Abstract][Full Text] [Related]
3. The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats. Li M; Zhou M; Wen P; Wang Q; Yang Y; Xiao H; Xie Z; Li X; Wang N; Wang J; Luo F; Chang J; Zhang W Exp Neurol; 2016 Aug; 282():27-36. PubMed ID: 27163550 [TBL] [Abstract][Full Text] [Related]
4. Oscillatory activity in the pedunculopontine area of patients with Parkinson's disease. Androulidakis AG; Mazzone P; Litvak V; Penny W; Dileone M; Gaynor LM; Tisch S; Di Lazzaro V; Brown P Exp Neurol; 2008 May; 211(1):59-66. PubMed ID: 18282571 [TBL] [Abstract][Full Text] [Related]
5. Pedunculopontine nucleus microelectrode recordings in movement disorder patients. Weinberger M; Hamani C; Hutchison WD; Moro E; Lozano AM; Dostrovsky JO Exp Brain Res; 2008 Jun; 188(2):165-74. PubMed ID: 18347783 [TBL] [Abstract][Full Text] [Related]
6. Effect of l-DOPA on local field potential relationship between the pedunculopontine nucleus and primary motor cortex in a rat model of Parkinson's disease. Geng X; Wang X; Xie J; Zhang X; Wang X; Hou Y; Lei C; Li M; Han H; Yao X; Zhang Q; Wang M Behav Brain Res; 2016 Dec; 315():1-9. PubMed ID: 27515286 [TBL] [Abstract][Full Text] [Related]
7. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240 [TBL] [Abstract][Full Text] [Related]
8. Pedunculopontine Nucleus Deep Brain Stimulation for Parkinsonian Disorders: A Case Series. Dayal V; Rajabian A; Jahanshahi M; Aviles-Olmos I; Cowie D; Peters A; Day B; Hyam J; Akram H; Limousin P; Hariz M; Zrinzo L; Foltynie T Stereotact Funct Neurosurg; 2021; 99(4):287-294. PubMed ID: 33279909 [TBL] [Abstract][Full Text] [Related]
9. Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus. Tattersall TL; Stratton PG; Coyne TJ; Cook R; Silberstein P; Silburn PA; Windels F; Sah P Nat Neurosci; 2014 Mar; 17(3):449-54. PubMed ID: 24487235 [TBL] [Abstract][Full Text] [Related]
11. Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA. Di Giovanni G; Chagraoui A; Puginier E; Galati S; De Deurwaerdère P Neurobiol Dis; 2019 Aug; 128():9-18. PubMed ID: 30149181 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological study in progressive supranuclear palsy with pedunculopontine stimulation. Hazrati LN; Wong JC; Hamani C; Lozano AM; Poon YY; Dostrovsky JO; Hutchison WD; Zadikoff C; Moro E Mov Disord; 2012 Sep; 27(10):1304-7. PubMed ID: 22865554 [TBL] [Abstract][Full Text] [Related]
13. Clinical Experience with Pedunculopontine Nucleus Stimulation in Conditions with Nigrostriatal Disconnection. Rowe J; Khan A; Romanowski C; Isaac C; Khan S; Mair R; Aziz T; Yianni J World Neurosurg; 2016 May; 89():9-18. PubMed ID: 26704205 [TBL] [Abstract][Full Text] [Related]
14. Oscillations in pedunculopontine nucleus in Parkinson's disease and its relationship with deep brain stimulation. Li M; Zhang W Front Neural Circuits; 2015; 9():47. PubMed ID: 26388741 [TBL] [Abstract][Full Text] [Related]
15. Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy. Ma J; Zhang G; Zhao Z; Chan P; Ye Z Brain Behav; 2024 Jul; 14(7):e3606. PubMed ID: 38945805 [TBL] [Abstract][Full Text] [Related]
16. What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease? Thevathasan W; Moro E Neurobiol Dis; 2019 Aug; 128():67-74. PubMed ID: 29933055 [TBL] [Abstract][Full Text] [Related]
17. Deep brain stimulation of the pedunculopontine nucleus for treatment of gait and balance disorder in progressive supranuclear palsy: Effects of frequency modulations and clinical outcome. Galazky I; Kaufmann J; Lorenzl S; Ebersbach G; Gandor F; Zaehle T; Specht S; Stallforth S; Sobieray U; Wirkus E; Casjens F; Heinze HJ; Kupsch A; Voges J Parkinsonism Relat Disord; 2018 May; 50():81-86. PubMed ID: 29503154 [TBL] [Abstract][Full Text] [Related]
18. Levodopa affects spike and local field synchronisation in the pedunculopontine nucleus of a rat model of Parkinson's disease. Zhang H; Xie J; Li Y; Liu H; Liu C; Kan D; Geng X; Wei S Aging (Albany NY); 2021 Feb; 13(5):7314-7329. PubMed ID: 33639616 [TBL] [Abstract][Full Text] [Related]
19. The pedunculopontine nucleus in Parkinson's disease: primate studies. Nandi D; Jenkinson N; Stein J; Aziz T Br J Neurosurg; 2008; 22 Suppl 1():S4-8. PubMed ID: 19085345 [TBL] [Abstract][Full Text] [Related]